J
Joan Puig-Barberà
Researcher at University of Valencia
Publications - 95
Citations - 3738
Joan Puig-Barberà is an academic researcher from University of Valencia. The author has contributed to research in topics: Vaccination & Influenza vaccine. The author has an hindex of 27, co-authored 85 publications receiving 2964 citations. Previous affiliations of Joan Puig-Barberà include Generalitat Valenciana.
Papers
More filters
Journal ArticleDOI
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal,Anthony L. Cunningham,Olivier Godeaux,Roman Chlibek,Javier Díez-Domingo,Shinn-Jang Hwang,Myron J. Levin,Janet E. McElhaney,Airi Poder,Joan Puig-Barberà,Timo Vesikari,Daisuke Watanabe,Lily Yin Weckx,Toufik Zahaf,Thomas C. Heineman +14 more
TL;DR: The HZ/su vaccine significantly reduced the risk of herpes zoster in adults who were 50 years of age or older and was similar to that in the other two age groups.
Journal ArticleDOI
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Anthony L. Cunningham,Himal Lal,Martina Kovac,Roman Chlibek,Shinn-Jang Hwang,Javier Díez-Domingo,Olivier Godeaux,Myron J. Levin,Janet E. McElhaney,Joan Puig-Barberà,C. Vanden Abeele,Timo Vesikari,Daisuke Watanabe,Toufik Zahaf,Anitta Ahonen,Eugene Athan,J. F. Barba-Gomez,Laura Campora,F. de Looze,H. J. Downey,Wayne Ghesquiere,Iris Gorfinkel,Tiina Korhonen,Edward M. F. Leung,Shelly A. McNeil,Lidia Oostvogels,Lars Rombo,Jan Smetana,Lily Yin Weckx,Wilfred W Yeo,Thomas C. Heineman +30 more
TL;DR: HZ/su was found to reduce the risks of herpes zoster and postherpetic neuralgia among adults 70 years of age or older.
Journal ArticleDOI
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
Alexander Domnich,Lucia Arata,Daniela Amicizia,Joan Puig-Barberà,Roberto Gasparini,Donatella Panatto +5 more
TL;DR: The results suggest that MF59-TIV is effective in reducing several influenza- related outcomes among the elderly, especially hospitalizations due to influenza-related complications.
Journal ArticleDOI
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
You-yi Li,Xin Wang,Dianna M. Blau,Mauricio T. Caballero,Daniel R. Feikin,Christopher Hill,Shabir A. Madhi,Saad B. Omer,Eric A. F. Simões,Harry Campbell,Ana Pariente,Darmaa Bardach,Quique Bassat,Jean-Sébastien Casalegno,Giorgi Chakhunashvili,Nigel W Crawford,Daria Danilenko,Lien Anh Ha Do,Marcela Echavarria,Angela Gentile,Aubree Gordon,Terho Heikkinen,Q. Sue Huang,Sophie Jullien,Anand Krishnan,Eduardo López,Joško Markić,Ainara Mira-Iglesias,Hannah C. Moore,Jocelyn Moyes,Lawrence Mwananyanda,D. James Nokes,Faseeha Noordeen,Evangeline Obodai,Nandhini Palani,Candice Romero,Vahid Salimi,Ashish Satav,Eu Jin Seo,Zakhar Shchomak,Rosalyn J. Singleton,Kirill Stolyarov,Sonia K. Stoszek,Anne von Gottberg,Danielle F. Wurzel,Lay-Myint Yoshida,Chee Fu Yung,Heather J. Zar,Harish Nair,Michael E. Abram,Jeroen Aerssens,A. M. Alafaci,Angel Balmaseda,Teresa Bandeira,Ian G. Barr,Ena Batinović,Philippe Beutels,Jinal N. Bhiman,Christopher C Blyth,Louis Bont,Sara S Bressler,Cheryl Cohen,Rachel Cohen,Anna Maria G. Costa,Rowena Crow,Andrew J Daley,Duc Anh Dang,Clarisse Demont,Chris A. Desnoyers,Javier Díez-Domingo,Maduja V M Divarathna,Mignon du Plessis,Madeleine Edgoose,F. Martin Ferolla,Thea Kølsen Fischer,Amanuel Tesfay Gebremedhin,Carlo Giaquinto,Yves Gillet,Roger Hernandez,C Horvat,Etienne Javouhey,Irakli Karseladze,John Kubale,Rakesh Kumar,Bruno Lina,Florencia Lución,Rae Macginty,Federico Martinón-Torres,Alissa McMinn,Adam Meijer,Petra Milić,Adrian Morel,Kim Mulholland,Tuya Mungun,Nickson Murunga,Claire Newbern,Mark P. Nicol,John Kofi Odoom,Peter J. M. Openshaw,Dominique Ploin,Fernando P. Polack,Andrew J. Pollard,Namrata Prasad,Joan Puig-Barberà,Janine Reiche,Noelia Reyes,Bishoy Rizkalla,Shilpa Satao,Ting Shi,Sujatha Sistla,Matthew D. Snape,Yanran Song,Giselle Soto,Forough Tavakoli,Michiko Toizumi,Naranzul Tsedenbal,Maarten van den Berge,Charlotte Vernhes,Claire von Mollendorf,Sibongile Walaza,Gregory J. Walker +120 more
TL;DR: This systematic analysis aims to update RSV-associated acute lower respiratory infection morbidity and mortality at global, regional, and national levels in children aged 0–60 months for 2019, with focus on overall mortality and narrower infant age groups that are targeted by RSV prophylactics in development.
Journal ArticleDOI
Influenza control in the 21st century: Optimizing protection of older adults.
Arnold S. Monto,Filippo Ansaldi,Richard Aspinall,Janet E. McElhaney,Janet E. McElhaney,Luis F. Montaño,Kristin L. Nichol,Joan Puig-Barberà,Joe Schmitt,Iain Stephenson +9 more
TL;DR: While it is clear that vaccines with greater immunogenicity are required for older adults, and that adjuvanted vaccines may offer a short-term solution, further research is required to exploit the many other new technologies.